Huiming Xia

Huiming Xia has extensive experience in the pharmaceutical and regulatory sectors, currently serving as a Director at Bristol Myers Squibb and having previously held the position of Associate Director. Prior experience includes roles at the FDA as a Senior Clinical Pharmacology Reviewer and Clinical Pharmacology Reviewer in Oncology, along with an ORISE Fellowship. Academic qualifications are highlighted by a Postdoctoral Fellowship at Johns Hopkins University and a Research Assistant position at the University of Florida.